Psoriasis Clearance Rates Higher With Bimekizumab vs Secukinumab Psoriasis Clearance Rates Higher With Bimekizumab vs Secukinumab

At 4 months, 62% of those on bimekizumab had complete clearance.Medscape Medical News

Source: Medscape Dermatology Headlines - April 24, 2021 Category: Dermatology Tags: Dermatology News Source Type: news